The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study - PubMed
The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study
Julie Phukan et al. J Neurol Neurosurg Psychiatry. 2012 Jan.
Abstract
Background: Despite considerable interest, the population-based frequency, clinical characteristics and natural history of cognitive impairment in amyotrophic lateral sclerosis (ALS) are not known.
Methodology: The authors undertook a prospective population-based study of cognitive function in 160 incident Irish ALS patients and 110 matched controls. Home-based visits were conducted to collect demographic and neuropsychological data. Patients were classified using the recently published consensus criteria and by a domain-based classification of both executive and non-executive cognitive processes.
Results: 13.8% of patients fulfilled the Neary criteria for frontotemporal dementia. In addition, 34.1% of ALS patients without evidence of dementia fulfilled the recently published consensus criteria for cognitive impairment. Non-demented ALS patients had a significantly higher frequency of impairment in language and memory domains compared to healthy controls. These deficits occurred primarily in patients with executive dysfunction. 14% of ALS patients had evidence of cognitive impairment without executive dysfunction, and no cognitive abnormality was detected in almost half the cohort (46.9%).
Conclusion: Co-morbid dementia occurs in approximately 14% of patients with a new diagnosis of ALS. Cognitive impairment, predominantly but not exclusively in the form executive dysfunction, is present in more than 40% of ALS patients who have no evidence of dementia. Cognitive impairment in ALS is not a universal feature, and its manifestations may be more heterogeneous than previously recognised.
Similar articles
-
An observational study of cognitive impairment in amyotrophic lateral sclerosis.
Rippon GA, Scarmeas N, Gordon PH, Murphy PL, Albert SM, Mitsumoto H, Marder K, Rowland LP, Stern Y. Rippon GA, et al. Arch Neurol. 2006 Mar;63(3):345-52. doi: 10.1001/archneur.63.3.345. Arch Neurol. 2006. PMID: 16533961
-
Neural substrate of cognitive theory of mind impairment in amyotrophic lateral sclerosis.
Carluer L, Mondou A, Buhour MS, Laisney M, Pélerin A, Eustache F, Viader F, Desgranges B. Carluer L, et al. Cortex. 2015 Apr;65:19-30. doi: 10.1016/j.cortex.2014.12.010. Epub 2014 Dec 29. Cortex. 2015. PMID: 25618325
-
Dysexecutive functioning in ALS patients and its clinical implications.
Kasper E, Schuster C, Machts J, Bittner D, Vielhaber S, Benecke R, Teipel S, Prudlo J. Kasper E, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):160-71. doi: 10.3109/21678421.2015.1026267. Epub 2015 May 12. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 25967541
-
The cognitive profile of ALS: a systematic review and meta-analysis update.
Beeldman E, Raaphorst J, Klein Twennaar M, de Visser M, Schmand BA, de Haan RJ. Beeldman E, et al. J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):611-9. doi: 10.1136/jnnp-2015-310734. Epub 2015 Aug 17. J Neurol Neurosurg Psychiatry. 2016. PMID: 26283685 Review.
-
Frontotemporal Dysfunction and Dementia in Amyotrophic Lateral Sclerosis.
Woolley SC, Strong MJ. Woolley SC, et al. Neurol Clin. 2015 Nov;33(4):787-805. doi: 10.1016/j.ncl.2015.07.011. Epub 2015 Sep 8. Neurol Clin. 2015. PMID: 26515622 Review.
Cited by
-
Mitochondrial Dysregulation and the Influence in Neurodegenerative Diseases.
Zuccoli GS, Carregari VC. Zuccoli GS, et al. Adv Exp Med Biol. 2022;1382:109-118. doi: 10.1007/978-3-031-05460-0_8. Adv Exp Med Biol. 2022. PMID: 36029407
-
Proudfoot M, Rohenkohl G, Quinn A, Colclough GL, Wuu J, Talbot K, Woolrich MW, Benatar M, Nobre AC, Turner MR. Proudfoot M, et al. Hum Brain Mapp. 2017 Jan;38(1):237-254. doi: 10.1002/hbm.23357. Epub 2016 Sep 13. Hum Brain Mapp. 2017. PMID: 27623516 Free PMC article.
-
Exploring sarcasm detection in amyotrophic lateral sclerosis using ecologically valid measures.
Staios M, Fisher F, Lindell AK, Ong B, Howe J, Reardon K. Staios M, et al. Front Hum Neurosci. 2013 May 21;7:178. doi: 10.3389/fnhum.2013.00178. eCollection 2013. Front Hum Neurosci. 2013. PMID: 23734113 Free PMC article.
-
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.
Borghero G, Pugliatti M, Marrosu F, Marrosu MG, Murru MR, Floris G, Cannas A, Parish LD, Cau TB, Loi D, Ticca A, Traccis S, Manera U, Canosa A, Moglia C, Calvo A, Barberis M, Brunetti M, Renton AE, Nalls MA, Traynor BJ, Restagno G, Chiò A; ITALSGEN and SARDINALS consortia. Borghero G, et al. Neurobiol Aging. 2015 Oct;36(10):2906.e1-5. doi: 10.1016/j.neurobiolaging.2015.06.013. Epub 2015 Jun 25. Neurobiol Aging. 2015. PMID: 26208502 Free PMC article.
-
Moglia C, Calvo A, Canosa A, Manera U, Vasta R, Di Pede F, Daviddi M, Matteoni E, Brunetti M, Sbaiz L, Cabras S, Gallone S, Grassano M, Peotta L, Palumbo F, Mora G, Iazzolino B, Chio A. Moglia C, et al. Neurology. 2024 Feb 27;102(4):e208082. doi: 10.1212/WNL.0000000000208082. Epub 2024 Jan 23. Neurology. 2024. PMID: 38261982 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous